Information  X 
Enter a valid email address

Company Name matching 'Merus N.V'

Date
Time Source
Company
Announcement
27 Jul 2020 1:00 pm GNW   Merus N.V. Merus Appoints Andrew Joe, M.D., as Chief Medical Officer
  1:00 pm GNW   Merus N.V. Merus announces FDA Orphan Drug Designation of Zenocutuzumab for the Treatment of Pancreatic Cancer
13 Jul 2020 9:01 pm GNW   Merus N.V. Merus and Caris Life Sciences Announce Collaboration to Detect NRG1 Fusions in Cancer Patients
01 Jun 2020 9:05 pm GNW   Merus N.V. Merus to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference
14 May 2020 2:05 pm GNW   Merus N.V. Merus Announces the Acceptance of Six Abstracts at Upcoming Medical Conferences and Provides Program Updates
11 May 2020 9:36 pm GNW   Merus N.V. Merus Announces Financial Results for the First Quarter and Provides Business Update
12 Mar 2020 8:01 pm GNW   Merus N.V. Merus Announces Financial Results for the Fourth Quarter and Full Year 2019 and Provides Business Update
16 Dec 2019 1:30 pm GNW   Merus N.V. Merus Announces Chief Executive Officer Transition
12 Nov 2019 9:01 pm GNW   Merus N.V. Merus Announces Financial Results for the Third Quarter 2019 and Provides Business Update
05 Nov 2019 1:32 pm GNW   Merus N.V. Merus Announces Pricing of Public Offering of Common Shares
04 Nov 2019 9:54 pm GNW   Merus N.V. Merus N.V. Announces Proposed Underwritten Public Offering of Common Shares
27 Oct 2019 3:50 pm GNW   Merus N.V. Merus Bispecific Antibody MCLA-128 Shows Encouraging Early Clinical Activity in Patients with Cancers Harboring NRG1 Gene Fusions
25 Oct 2019 4:05 pm GNW   Merus N.V. Merus Announces Presentation and Poster on MCLA-128 and MCLA-129 Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
03 Jun 2019 1:28 pm GNW   Merus N.V. Merus to Present at the Jefferies 2019 Healthcare Conference
30 May 2019 9:05 pm GNW   Merus N.V. Merus Announces Financial Results for the First Quarter 2019 and Provides Business Update
23 May 2019 1:00 pm GNW   Merus N.V. Merus Announces 2019 Annual General Meeting of Shareholders
20 May 2019 1:38 pm GNW   Merus N.V. Merus to Present at the RBC Capital Markets 2019 Healthcare Conference
09 May 2019 1:00 pm GNW   Merus N.V. Merus Announces First Patient Treated in Phase 1 Clinical Trial of MCLA-145 for Advanced Solid Tumors
03 Apr 2019 9:00 pm GNW   Merus N.V. Merus Announces Financial Results for the Full Year 2018 and Provides Business Update
01 Apr 2019 12:00 pm GNW   Merus N.V. Merus and Incyte Present MCLA-145 Program Preclinical Data at the AACR Annual Meeting 2019
11 Mar 2019 12:09 pm GNW   Merus N.V. Merus to Present at the Cowen & Co. 39th Annual Health Care Conference
07 Feb 2019 12:00 pm GNW   Merus N.V. Merus to Participate in Guggenheim Healthcare Talks Idea Forum
07 Jan 2019 12:00 pm GNW   Merus N.V. Merus Announces IND Clearance for MCLA-145
02 Jan 2019 1:00 pm GNW   Merus N.V. Merus Announces Strategic Collaboration with Betta Pharmaceuticals to Develop and Commercialize MCLA-129 in China
27 Dec 2018 10:05 pm GNW   Merus N.V. Merus Announces Financial Results for the Third Quarter 2018 and Provides Business Update
20 Dec 2018 9:45 pm GNW   Merus N.V. Merus Announces Global Settlement and End to All Patent Litigation with Regeneron Pharmaceuticals
08 Nov 2018 12:00 pm GNW   Merus N.V. Merus to Present at the Jefferies 2018 London Healthcare Conference
27 Sep 2018 9:00 pm GNW   Merus N.V. Merus to Present at the Cantor Fitzgerald Global Healthcare Conference
  12:00 pm GNW   Merus N.V. Merus Strengthens Team with Key Appointments
30 Aug 2018 12:00 pm GNW   Merus N.V. Merus to Participate in Citi’s 13th Annual Biotech Conference
22 Aug 2018 12:00 pm GNW   Merus N.V. Merus Announces Formation of a Scientific Advisory Board
10 Aug 2018 1:35 pm GNW   Merus N.V. Merus Announces Financial Results for the Second Quarter 2018 & Mid-year Operating Results
07 Aug 2018 12:00 pm GNW   Merus N.V. Merus to Present at the 2018 Wedbush PacGrow Healthcare Conference
26 Jul 2018 12:00 pm GNW   Merus N.V. Merus N.V. : Merus Announces Recent Corporate Developments and Financial Results for the First Quarter 2018
05 Jul 2018 9:00 am GNW   Merus N.V. Merus Announces Annual Meeting of Shareholders
31 May 2018 12:00 pm GNW   Merus N.V. Merus to Present at the Jefferies 2018 Healthcare Conference
24 May 2018 12:00 pm GNW   Merus N.V. Merus Announces First Patient Dosed in Phase 1 Clinical Trial of MCLA-158 in Patients with Solid Tumors
15 May 2018 12:00 pm GNW   Merus N.V. Merus Announces Unique Mechanism of Action of MCLA-128 That Potently Blocks HER3 Signaling Published in Cancer Cell
26 Apr 2018 12:00 pm GNW   Merus N.V. Merus Announces Recent Corporate Developments and Financial Results for the Fourth Quarter and Full Year 2017
19 Apr 2018 12:00 pm GNW   Merus N.V. Merus to Report Full Year 2017 Financial Results and Corporate Developments on April 26, 2018
20 Mar 2018 11:00 am GNW   Merus N.V. Merus and the Vall d'Hebron Institute of Oncology Announce Research Collaboration to Develop Innovative Bispecific Antibodies for Therapeutic Applications in the Treatment of Cancer
14 Mar 2018 11:00 am GNW   Merus N.V. Merus Announces Ono Pharmaceuticals Exercise of its Option for New Research and License Agreement to Generate Bispecific Antibody Targeting Autoimmune Diseases
13 Mar 2018 11:00 am GNW   Merus N.V. Merus' Intellectual Property Portfolio Expands with Two New Patents
06 Mar 2018 12:00 pm GNW   Merus N.V. Merus to Present at the Cowen & Co. 38th Annual Health Care Conference
05 Feb 2018 12:00 pm GNW   Merus N.V. Merus Announces Participation in Four Investor Conferences in February 2018
08 Jan 2018 12:00 pm GNW   Merus N.V. Merus and Simcere Announce Strategic Collaboration on Multiple Bispecific Antibodies
04 Jan 2018 12:00 pm GNW   Merus N.V. Merus Provides Clinical Updates for MCLA-117 and MCLA-158 Programs
02 Jan 2018 12:30 pm GNW   Merus N.V. Merus to Present at the 36th Annual J.P. Morgan Healthcare Conference
27 Dec 2017 12:30 pm GNW   Merus N.V. Merus Announces the U.S. Court of Appeals for the Federal Circuit Denies Regeneron's Petition to Rehear the Panel's Decision Affirming Merus' Inequitable Conduct Claim Against Regeneron
30 Nov 2017 12:00 pm GNW   Merus N.V. Merus Announces Third Quarter 2017 Financial Results and Clinical Highlights
09 Nov 2017 12:30 pm GNW   Merus N.V. Merus to Present at the Jefferies London Healthcare Conference
10 Oct 2017 9:08 pm GNW   Merus N.V. Merus to Participate in the BIO Investor Forum
19 Sep 2017 9:05 pm GNW   Merus N.V. Merus Announces Second Quarter 2017 Financial Results and Highlights Recent Progress
30 Aug 2017 12:00 pm GNW   Merus N.V. Merus to Participate in Two Investor Conferences in September 2017
09 Aug 2017 12:00 pm GNW   Merus N.V. Merus to Present at the 2017 Wedbush PacGrow Healthcare Conference
28 Jul 2017 12:02 pm GNW   Merus N.V. U.S. Court of Appeals for the Federal Circuit Affirms Merus' Inequitable Conduct Claim Against Regeneron
11 Jul 2017 9:05 pm GNW   Merus N.V. Merus Announces First Quarter 2017 Financial Results and Mid-Year Operating Results
07 Jul 2017 4:52 pm GNW   Merus N.V. Merus to Report First Quarter 2017 Financial & Mid-Year Operating Results on July 11, 2017


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t